The last 10 years have seen major advances in the field of microscopy with the development of new forms of microscopy and specimen preparation procedures. We have available to cancer investigators the ability to specifically tag proteins, carbohydrates, and nucleic acid sequences using specific antibodies or labeled complementary nucleic acid sequences. We can also facilitate the use of fluorescence molecules for localizing specific cellular structures, proteins and nucleic acids, and for viewing and measuring physiological alterations in specific organelles. With the increased variety and sophistication of microscopes utilized in the Core, the value added by the specialized knowledge of the Director Dr. Jay Jerome and the Core technicians becomes an essential component, enabling seasoned investigators to utilizes the tools and efficiently advising novice users on which of the variety of techniques is most appropriate to their research. The facility maintains a full service preparative laboratory and houses standard wide field fluorescent microscopes a Philips 400 Transmission (120 KeV) Electron Microscope, Philips 515 Analytical Scanning Electron Microscope, Philips CM-30 Intermediate Voltage (300 KeV) Transmission Electron Microscope, Zeiss 510 Laser Scanning Confocal Microscope, Zeiss upright and inverted widefield microscopes equipped for video and digital imaging, and a Arcturus Pixcell II Laser Dissection Microscope. The Zeiss inverted microscope is equipped with a temperature and environment controlled chamber for use with the Zeiss inverted microscope This allows along term, live cell experiments in a controlled CO2 environment. Funding of this Core is slightly different from the funding of other Cores. Usage of the CCCWFU-funded portion of the Microscopy Core Laboratory by Cancer Center approved project is by definition 100% since support is in the form of a charge-back supplement, which is only given to approved cancer-focused, funded projects. Over the past two years, due to the substantial reduction in the size of the Cancer Center in the current proposal we are requesting $20,516 which will be used as a supplement for fee for service charge by the laboratory to projects of CCWFU membership.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA012197-27
Application #
6424499
Study Section
Project Start
1976-03-01
Project End
2006-01-31
Budget Start
1998-10-01
Budget End
1999-09-30
Support Year
27
Fiscal Year
2001
Total Cost
$53,375
Indirect Cost
Name
Wake Forest University Health Sciences
Department
Type
DUNS #
041418799
City
Winston-Salem
State
NC
Country
United States
Zip Code
27106
Westcott, Marlena M; Clemens, Elene A; Holbrook, Beth C et al. (2018) The choice of linker for conjugating R848 to inactivated influenza virus determines the stimulatory capacity for innate immune cells. Vaccine 36:1174-1182
Ruiz, Jimmy; Miller, Antonius A; Tooze, Janet A et al. (2018) Frailty assessment predicts toxicity during first cycle chemotherapy for advanced lung cancer regardless of chronologic age. J Geriatr Oncol :
Levine, Edward A; Votanopoulos, Konstantinos I; Shen, Perry et al. (2018) A Multicenter Randomized Trial to Evaluate Hematologic Toxicities after Hyperthermic Intraperitoneal Chemotherapy with Oxaliplatin or Mitomycin in Patients with Appendiceal Tumors. J Am Coll Surg 226:434-443
Addington, Elizabeth L; Sohl, Stephanie J; Tooze, Janet A et al. (2018) Convenient and Live Movement (CALM) for women undergoing breast cancer treatment: Challenges and recommendations for internet-based yoga research. Complement Ther Med 37:77-79
Park, Sun H; Keller, Evan T; Shiozawa, Yusuke (2018) Bone Marrow Microenvironment as a Regulator and Therapeutic Target for Prostate Cancer Bone Metastasis. Calcif Tissue Int 102:152-162
Haas, Karen M; Johnson, Kristen L; Phipps, James P et al. (2018) CD22 Promotes B-1b Cell Responses to T Cell-Independent Type 2 Antigens. J Immunol 200:1671-1681
Suo, Xubin; Eldridge, Brittany N; Zhang, Han et al. (2018) P-Glycoprotein-Targeted Photothermal Therapy of Drug-Resistant Cancer Cells Using Antibody-Conjugated Carbon Nanotubes. ACS Appl Mater Interfaces 10:33464-33473
Widner, D Brooke; Park, Sun H; Eber, Matthew R et al. (2018) Interactions Between Disseminated Tumor Cells and Bone Marrow Stromal Cells Regulate Tumor Dormancy. Curr Osteoporos Rep 16:596-602
Liu, Liang; Ruiz, Jimmy; O'Neill, Stacey S et al. (2018) Favorable outcome of patients with lung adenocarcinoma harboring POLE mutations and expressing high PD-L1. Mol Cancer 17:81
Sirkisoon, Sherona R; Carpenter, Richard L; Rimkus, Tadas et al. (2018) Interaction between STAT3 and GLI1/tGLI1 oncogenic transcription factors promotes the aggressiveness of triple-negative breast cancers and HER2-enriched breast cancer. Oncogene 37:2502-2514

Showing the most recent 10 out of 548 publications